The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.

Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

The U.S. Food and Drug Administration’s decision to limit COVID vaccines to people 65 and older and others with underlying ...

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

Complicating matters, however, were new FDA rules for the updated Covid vaccines, announced just days earlier, that would ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

FDA Commissioner Marty Makary and top U.S. vaccines regulator Vinay Prasad wrote ... six previous doses of a Covid-19 vaccine will benefit from the seventh dose,” Prasad and Makary wrote.

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...